Patents Assigned to IMMUNEPHARMA S.R.L.
  • Method of treating cancer using a caspase-4 inhibitor
    Patent number: 10976318
    Abstract: The present invention relates to the use as a biomarker of the active form of a human caspase protein, preferably the human caspase-4 or caspase-1, or of the active form of the protein encoded by an orthologue gene of the human caspase protein, preferably by an orthologue gene of the human caspase-4, for example the murine caspase-11 protein, in a method of diagnosis and/or prognosis and/or of monitoring the progression of a tumor, particularly lung cancer.
    Type: Grant
    Filed: February 19, 2015
    Date of Patent: April 13, 2021
    Assignee: IMMUNEPHARMA S.R.L.
    Inventors: Aldo Pinto, Rita Patrizia Aquino, Rosalinda Sorrentino, Michela Terlizzi